Articles by Searching For Value, SA

  • Posted on 8/31/17

    Merck: Keytruda As A Growth Driver

    Merck (MRK) has been struggling to drive top-line growth for years, resulting in a lack of growth of its share price as well. But now, its . . .

  • Posted on 8/24/17

    Johnson & Johnson Is Doing Just Fine

    A growing number of investors seem to believe that Johnson & Johnson (JNJ) is overvalued after seeing some relatively weak financial results. The combination of a . . .

  • Posted on 7/27/17

    Pfizer's Worrying Trend

    In my last article about Pfizer (PFE) I discussed the upcoming loss of exclusivity (LOE) of certain brands and why I did not believe these would . . .

  • Posted on 7/10/17

    Altria: Perfectly Positioning Itself

    The tobacco industry is changing, with an increasing number of people trying to live healthier lives. Because of the fact that smoking cigarettes is not the . . .

  • Posted on 7/10/17

    Philip Morris's Future Looks Bright

    A new trend has investors worried about how Philip Morris International’s (PM) future will progress. A trend of people looking to live healthier is already starting . . .

  • Posted on 7/7/17

    Pfizer: Is It Really That Bad?

    A lot of investors seem to be quite pessimistic about Pfizer’s (PFE) future. The loss of exclusivity of certain important brands that are coming up are . . .

  • Posted on 6/27/17

    Teva: A Great Investment Opportunity

    Teva Pharmaceutical Industries (TEVA) has seen its shares under pressure for quite some time now. A lot of investors seem quite concerned about the company’s current . . .

  • Posted on 5/30/17

    Verizon: Take Your Money Elsewhere

    Last March, I wrote an article about why I believed investors should stay away from Verizon (NYSE:VZ). Now, after Verizon's shares have seen a decline of . . .

  • Posted on 4/17/17

    IBM: Analysts Underestimate Q1 EPS (Again)

    Wall Street analysts have been lowering their expectations for the first quarter quite a bit in the last three months. Three months ago, analysts still expected . . .

  • Posted on 4/10/17

    Under Armour: DCF Model Indicates 44% Upside

    A while ago I wrote an article about Under Armour (NYSE:UA) (NYSE:UAA). In that article, I discussed the current headwinds the company is facing and how . . .